The largest database of trusted experimental protocols

Danusertib

Manufactured by Apexbio
Sourced in United States

Danusertib is a small molecule inhibitor that targets Aurora kinases A, B, and C. It is a laboratory tool used for research purposes.

Automatically generated - may contain errors

2 protocols using danusertib

1

Preparation of Small Molecule Stocks

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMS-265246 (SelleckChem, Houston, TX, USA), RO-3306 (SelleckChem), K03861 (SelleckChem), LDC000067 (SelleckChem), THZ1 (SelleckChem), Rigosertib (ApexBio, Houston, TX, USA) and Danusertib (ApexBio) powders were dissolved in DMSO to a stock concentration of 10 mM. The chemical stock solutions were stored as small aliquots at -80 °C.
+ Open protocol
+ Expand
2

Pharmacological Interventions in Cancer Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
The administration of Carbenoxolone, Mefloquine and Danusertib
followed previous reports (Fraedrich et al.,
2012
; Keiser et al., 2011 (link);
Morecki et al., 1997 (link)) whereas the
dose of the two FDA-approved drugs, Everolimus and Arsenic trioxide were
adjusted from clinical human dose by FDA guidance: mouse dose(mg/kg)=human
dose X mouse Km (~37) / mouse Km (~3). Carbenoxolone (CBX,
C4790 Sigma) was injected i.p. daily at the dosage of 30 mg/kg. Mefloquine
(MEFL, 1379059 Sigma) was administrated once weekly by oral gavage at the
dosage of 50 mg/kg. Danusertib (A4116, ApexBio) were injected i.p. daily at
the dosage of 15 mg/kg. Arsenic trioxide (A1010, Sigma) was injected i.p.
daily at the dosage of 1.9 mg/kg (transferred from 0.15 mg/kg/day for
human). Everolimus (A8169, ApexBio) was administrated daily by oral gavage
at the dosage of 1 mg/kg. For IIA model, all drug treatments were
administrated from the day of injection till the end of experiment unless
specifically stated. For spontaneous model, treatments were administrated
after resection of primary tumors till the end of experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!